Exact Mass: 946.3959732000001

Exact Mass Matches: 946.3959732000001

Found 25 metabolites which its exact mass value is equals to given mass value 946.3959732000001, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Psma-hbed-CC

2-{[(1-carboxy-5-{[6-({3-[3-({[2-({[5-(2-carboxyethyl)-2-hydroxyphenyl]methyl}(carboxymethyl)amino)ethyl](carboxymethyl)amino}methyl)-4-hydroxyphenyl]-1-hydroxypropylidene}amino)-1-hydroxyhexylidene]amino}pentyl)-C-hydroxycarbonimidoyl]amino}pentanedioate

C44H62N6O17 (946.4171242)

20S-hydroxyvespertilin|3-O-(beta-sycophantetraosyl)-20S-3beta,16beta,20-trihydroxy-pregn-5-en-20-carboxylic acid (22,16)-lactone|3-O-{alpha-L-rhamnopyranosyl-(1>2)-O-[beta-D-xylopyranosyl-(1>2)-O-alpha-L-rhamnopyranosyl-(1>4)-]-beta-D-glucopyranosyl}-20S-3beta,16beta,20-trihydroxy-pregn-5-en-20-carboxylic acid (22,16)-lactone|solasodoside B

20S-hydroxyvespertilin|3-O-(beta-sycophantetraosyl)-20S-3beta,16beta,20-trihydroxy-pregn-5-en-20-carboxylic acid (22,16)-lactone|3-O-{alpha-L-rhamnopyranosyl-(1>2)-O-[beta-D-xylopyranosyl-(1>2)-O-alpha-L-rhamnopyranosyl-(1>4)-]-beta-D-glucopyranosyl}-20S-3beta,16beta,20-trihydroxy-pregn-5-en-20-carboxylic acid (22,16)-lactone|solasodoside B

C45H70O21 (946.4409370000001)

cerberalignan M

C50H58O18 (946.3622968)

C43H62N8O16

C43H62N8O16 (946.4283571999999)

C43H62O23

C43H62O23 (946.3681702)

Neu5Acα2-3[GalNAcβ1-4]Galβ1-4GlcNAcβ-Sp

C35H58N6O24 (946.3502308000001)

TRICYCLOHEXYLPHOSPHINE [1,3-BIS(2,4,6-TRIMETHYLPHENYL)IMIDAZOL-2-YLIDENE] [3-PHENYL-1H-INDEN-1-YLIDENE] RUTHENIUM (II) DICHLORIDE

C54H67Cl2N2PRu (946.3462052000001)

Nepadutant

C45H58N10O13 (946.4184618)

D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents

Ruzasvir

C49H55FN10O7S (946.3959732000001)

D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent

TT-232

C45H58N10O9S2 (946.3829458000001)

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones TT-232 (CAP-232), a somatostatin derivative, is a peptide SSTR1/SSTR4 agonist. TT-232 inhibits cancer cell proliferation and induces apoptosis. TT-232 is also a broad-spectrum anti-inflammatory and analgesic agent[1][2][4].

Gozetotide

C44H62N6O17 (946.4171242)

C1446 - Radiopharmaceutical Compound > C2124 - Radioconjugate

3x(L-Asp-L-Arg)-Asp

C34H58N16O16 (946.4216508)

4,6,12,19-Tetraazadocosane-1,3,7-tricarboxylic acid, 22-[3-[[[2-[[[5-(2-carboxyethyl)-2-hydroxyphenyl]methyl](carboxymethyl)amin

C44H62N6O17 (946.4171242)

Desferrialbomycin epsilon(3-)

C36H56N11O17S-3 (946.3576186)

LPIM2 20:3

C41H71O22P (946.4174395999999)

n-[(3s,7r,10z,13r,17s,22as)-1,8,11,14-tetrahydroxy-7-[(2s)-2-hydroxy-2-[(2-hydroxyethyl)-c-hydroxycarbonimidoyl]ethyl]-13-[2-(c-hydroxycarbonimidoyl)ethyl]-10-(1h-indol-3-ylmethylidene)-3-[2-(methylsulfanyl)ethyl]-4,5,18-trioxo-3h,6h,7h,13h,16h,17h,20h,21h,22h,22ah-pyrrolo[1,2-n]1,4,7,10,14,17-hexaazacycloicosan-17-yl]benzenecarboximidic acid

n-[(3s,7r,10z,13r,17s,22as)-1,8,11,14-tetrahydroxy-7-[(2s)-2-hydroxy-2-[(2-hydroxyethyl)-c-hydroxycarbonimidoyl]ethyl]-13-[2-(c-hydroxycarbonimidoyl)ethyl]-10-(1h-indol-3-ylmethylidene)-3-[2-(methylsulfanyl)ethyl]-4,5,18-trioxo-3h,6h,7h,13h,16h,17h,20h,21h,22h,22ah-pyrrolo[1,2-n]1,4,7,10,14,17-hexaazacycloicosan-17-yl]benzenecarboximidic acid

C44H54N10O12S (946.3643204000001)

n-(1,8,14-trihydroxy-7-{2-hydroxy-2-[(2-hydroxyethyl)-c-hydroxycarbonimidoyl]ethyl}-13-[2-(c-hydroxycarbonimidoyl)ethyl]-10-(1h-indol-3-ylmethylidene)-3-[2-(methylsulfanyl)ethyl]-4,5,11,18-tetraoxo-3h,6h,7h,12h,13h,16h,17h,20h,21h,22h,22ah-pyrrolo[1,2-n]1,4,7,10,14,17-hexaazacycloicosan-17-yl)benzenecarboximidic acid

n-(1,8,14-trihydroxy-7-{2-hydroxy-2-[(2-hydroxyethyl)-c-hydroxycarbonimidoyl]ethyl}-13-[2-(c-hydroxycarbonimidoyl)ethyl]-10-(1h-indol-3-ylmethylidene)-3-[2-(methylsulfanyl)ethyl]-4,5,11,18-tetraoxo-3h,6h,7h,12h,13h,16h,17h,20h,21h,22h,22ah-pyrrolo[1,2-n]1,4,7,10,14,17-hexaazacycloicosan-17-yl)benzenecarboximidic acid

C44H54N10O12S (946.3643204000001)

(4s,5e,6s)-5-ethylidene-4-(2-{[(1s,2r,3s,4s)-3-[({2-[(2s,3e,4s)-3-ethylidene-5-(methoxycarbonyl)-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,4-dihydropyran-4-yl]acetyl}oxy)methyl]-4-[(2s)-1-hydroxypropan-2-yl]-2-methylcyclopentyl]oxy}-2-oxoethyl)-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,6-dihydropyran-3-carboxylic acid

(4s,5e,6s)-5-ethylidene-4-(2-{[(1s,2r,3s,4s)-3-[({2-[(2s,3e,4s)-3-ethylidene-5-(methoxycarbonyl)-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,4-dihydropyran-4-yl]acetyl}oxy)methyl]-4-[(2s)-1-hydroxypropan-2-yl]-2-methylcyclopentyl]oxy}-2-oxoethyl)-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,6-dihydropyran-3-carboxylic acid

C43H62O23 (946.3681702)

(2s)-n-[(2s,5s,8r,11s,12s,15s,18s,21r)-5-benzyl-2,8-bis[(2r)-butan-2-yl]-6,13,16,21-tetrahydroxy-15-[2-(4-hydroxyphenyl)ethyl]-4,11-dimethyl-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2-hydroxy-3-(sulfooxy)propanimidic acid

(2s)-n-[(2s,5s,8r,11s,12s,15s,18s,21r)-5-benzyl-2,8-bis[(2r)-butan-2-yl]-6,13,16,21-tetrahydroxy-15-[2-(4-hydroxyphenyl)ethyl]-4,11-dimethyl-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2-hydroxy-3-(sulfooxy)propanimidic acid

C44H62N6O15S (946.3993662)

5-[(2s,3r,4s)-4-[(4-{[(1s,2r)-1,3-dihydroxy-1-(4-hydroxy-3-methoxyphenyl)propan-2-yl]oxy}-3-methoxyphenyl)methyl]-4-hydroxy-3-(hydroxymethyl)oxolan-2-yl]-5'-[(2r,3r,4s)-4-hydroxy-4-[(4-hydroxy-3-methoxyphenyl)methyl]-3-(hydroxymethyl)oxolan-2-yl]-3,3'-dimethoxy-[1,1'-biphenyl]-2,2'-diol

5-[(2s,3r,4s)-4-[(4-{[(1s,2r)-1,3-dihydroxy-1-(4-hydroxy-3-methoxyphenyl)propan-2-yl]oxy}-3-methoxyphenyl)methyl]-4-hydroxy-3-(hydroxymethyl)oxolan-2-yl]-5'-[(2r,3r,4s)-4-hydroxy-4-[(4-hydroxy-3-methoxyphenyl)methyl]-3-(hydroxymethyl)oxolan-2-yl]-3,3'-dimethoxy-[1,1'-biphenyl]-2,2'-diol

C50H58O18 (946.3622968)